Revenue: INR1,146 crores in Q3, a growth of 4% year-on-year. Branded Generic Sales: INR834 crores in Q3, a growth of 10%. International Business - Asia: INR316 crores in Q3, a growth of 8%.

The market for human insulin includes both branded and generic formulations, with major pharmaceutical companies being the primary manufacturers of insulin products. However, with the rise in the ...

Novo Nordisk A/S on Monday became the final insulin manufacturer to reach a proposed settlement agreement with Minnesota, tentatively ending a seven-year lawsuit over the affordability of the diabetes ...

The company has pivoted dramatically over the past several years, going from a major insulin provider to a ... even for us," Jonsson said of the awkward generic drug name, in an interview with ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...

(Thyroid) California Gov. Gavin Newsom's (D) plan to produce cheap, generic insulin is far behind schedule, industry experts said. (CalMatters) In related news, a federal law that made companies ...

Prosecutors in Raleigh County used the assertion to support their claim that Natalie killed her 38-year-old husband, Michael, in Feb. 2019 by injecting him with insulin as Michael’s blood sugar ...

Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians ... meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as ...

We remain the only company investing in a comprehensive ecosystem of differentiated technology for intensive insulin patients that takes on more ... extended reservoirs and extended-wear sets, plus a ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its ... commercialization of diabetes products including oral anti-diabetics and insulin. DiabTec's ...